Current and future pharmacotherapy options for non-cystic fibrosis bronchiectasis

被引：11
作者：
Athanazio, Rodrigo [1 ]
Cordeiro da Costa, Joao [2 ]
de la Rosa Carrillo, David [3 ]
Angel Martinez-Garcia, Miguel [4 ]
机构：
[1] Univ Sao Paulo, Pulm Div, Heart Inst InCor, Hosp Clin,Fac Med, Sao Paulo, Brazil
[2] Ctr Hosp Leiria, Dept Pneumol, Leiria, Portugal
[3] Platon Hosp, Pneumol Unit, Barcelona, Spain
[4] Polytech & Univ La Fe Hosp, Dept Pneumol, Avda Fernando Abril Marorell S-N, Valencia 46016, Spain
来源：
EXPERT REVIEW OF RESPIRATORY MEDICINE | 2018年 / 12卷 / 07期
关键词：
Bronchiectasis; bronchial infection; inhaled antibiotics; bronchodilators; inhaled steroids; mucus clearance techniques; mucoactive agents; macrolides; mucolytics; hypertonic agents; TERM MACROLIDE TREATMENT; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; CHRONIC BRONCHIAL INFECTION; RECOMBINANT HUMAN DNASE; DRY POWDER MANNITOL; PSEUDOMONAS-AERUGINOSA; LONG-TERM; DOUBLE-BLIND; LUNG-FUNCTION;
D O I：
10.1080/17476348.2018.1481392
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Introduction: In recent years, there has been an increasing number of clinical trials investigating the effect of pharmacological treatments on patients with bronchiectasis.Areas covered: This review provides an overview of current drugs used in bronchiectasis patients as well as those that could make a future contribution to the management of this disease.Expert commentary: Bronchiectasis is a very heterogeneous disease, so it can be studied from a phenotypic standpoint and its pathophysiological mechanisms (endotypes) can be defined. This provides an interesting field of research as it enables the identification of patients suitable for inclusion in specific clinical trials on new drugs.
引用
收藏
页码：569 / 584
页数：16
相关论文
共 133 条
  • [1] Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial
    Aaron, SD
    Vandemheen, KL
    Ferris, W
    Fergusson, D
    Tullis, E
    Haase, D
    Berthiaume, Y
    Brown, N
    Wilcox, P
    Yazghatlian, V
    Bye, P
    Bell, S
    Chan, F
    Rose, B
    Jeanneret, A
    Stephenson, A
    Noseworthy, M
    Freitag, A
    Paterson, N
    Doucette, S
    Harbour, C
    Ruel, M
    MacDonald, N
    [J]. LANCET, 2005, 366 (9484) : 463 - 471
  • [2] Treatable traits: toward precision medicine of chronic airway diseases
    Agusti, Alvar
    Bel, Elisabeth
    Thomas, Mike
    Vogelmeier, Claus
    Brusselle, Guy
    Holgate, Stephen
    Humbert, Marc
    Jones, Paul
    Gibson, Peter G.
    Vestbo, Jorgen
    Beasley, Richard
    Pavord, Ian D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (02) : 410 - 419
  • [3] Aksamit T, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02053-2017
  • [4] Azithromycin for Prevention of Exacerbations of COPD
    Albert, Richard K.
    Connett, John
    Bailey, William C.
    Casaburi, Richard
    Cooper, J. Allen D., Jr.
    Criner, Gerard J.
    Curtis, Jeffrey L.
    Dransfield, Mark T.
    Han, MeiLan K.
    Lazarus, Stephen C.
    Make, Barry
    Marchetti, Nathaniel
    Martinez, Fernando J.
    Madinger, Nancy E.
    McEvoy, Charlene
    Niewoehner, Dennis E.
    Porsasz, Janos
    Price, Connie S.
    Reilly, John
    Scanlon, Paul D.
    Sciurba, Frank C.
    Scharf, Steven M.
    Washko, George R.
    Woodruff, Prescott G.
    Anthonisen, Nicholas R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (08) : 689 - 698
  • [5] Clinical phenotypes in adult patients with bronchiectasis
    Aliberti, Stefano
    Lonni, Sara
    Dore, Simone
    McDonnell, Melissa J.
    Goeminne, Pieter C.
    Dimakou, Katerina
    Fardon, Thomas C.
    Rutherford, Robert
    Pesci, Alberto
    Restrepo, Marcos I.
    Sotgiu, Giovanni
    Chalmers, James D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (04) : 1113 - 1122
  • [6] Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BAT Randomized Controlled Trial
    Altenburg, Josje
    de Graaff, Casper S.
    Stienstra, Ymkje
    Sloos, Jacobus H.
    van Haren, Eric H. J.
    Koppers, Ralph J. H.
    van der Werf, Tjip S.
    Boersma, Wim G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (12): : 1251 - 1259
  • [7] Effect of probiotics on respiratory, gastrointestinal and nutritional outcomes in patients with cystic fibrosis: A systematic review
    Anderson, Jacqueline L.
    Miles, Caitlin
    Tierney, Audrey C.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (02) : 186 - 197
  • [8] Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis
    Andrejak, Claire
    Nielsen, Rikke
    Thomsen, Vibeke O.
    Duhaut, Pierre
    Sorensen, Henrik Toft
    Thomsen, Reimar Wernich
    [J]. THORAX, 2013, 68 (03) : 256 - 262
  • [9] Bronchiectasis: Rising from its own ashes
    Angel Martinez-Garcia, Miguel
    de la Rosa-Carrillo, David
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (02): : 59 - 60
  • [10] Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults
    Angel Martinez-Garcia, Miguel
    Maiz, Luis
    Olveira, Casilda
    Maria Giron, Rosa
    de la Rosa, David
    Blanco, Marina
    Canton, Rafael
    Vendrell, Montserrat
    Polverino, Eva
    de Gracia, Javier
    Prados, Concepcion
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (02): : 79 - 87
12345678910